Skip to main content

Peer Review reports

From: Feasibility of randomizing Danish citizens aged 65–79 years to high-dose quadrivalent influenza vaccine vs. standard-dose quadrivalent influenza vaccine in a pragmatic registry-based setting: rationale and design of the DANFLU-1 Trial

Original Submission
1 Mar 2022 Submitted Original manuscript
8 Mar 2022 Author responded Author comments - Niklas Dyrby Johansen
Resubmission - Version 2
8 Mar 2022 Submitted Manuscript version 2
23 Mar 2022 Author responded Author comments - Niklas Dyrby Johansen
Resubmission - Version 3
23 Mar 2022 Submitted Manuscript version 3
Publishing
4 Apr 2022 Editorially accepted
21 Apr 2022 Article published 10.1186/s40814-022-01044-w

You can find further information about peer review here.

Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784